Teva Pharmaceutical Industries Ltd
TEVA30.330USD
+0.010+0.03%
收盘 12/19, 16:00（美东）报价延迟15分钟
34.80B总市值
48.75市盈率 TTM
关于 Teva Pharmaceutical Industries Ltd 公司
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd简介
公司代码TEVA
公司名称Teva Pharmaceutical Industries Ltd
上市日期Feb 06, 2087
CEOFrancis (Richard D)
员工数量33892
证券类型Depository Receipt
年结日Feb 06
公司地址124 Dvora Hanevi'a St.
城市TEL AVIV-YAFO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Israel
邮编6944020
电话97239148213
网址https://www.tevapharm.com/
公司代码TEVA
上市日期Feb 06, 2087
CEOFrancis (Richard D)
Teva Pharmaceutical Industries Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
其他
501.00M
12.00%
地区USD
名称
营收
占比
United States
2.15B
51.51%
Europe
1.30B
31.06%
International Markets
495.00M
11.85%
Other
232.00M
5.56%
业务
地区
业务USD
名称
营收
占比
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
其他
501.00M
12.00%
股东统计
更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
其他
83.84%
持股股东
持股股东
占比
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
其他
83.84%
股东类型
持股股东
占比
Investment Advisor
22.99%
Investment Advisor/Hedge Fund
12.47%
Hedge Fund
10.45%
Insurance Company
6.24%
Research Firm
2.35%
Pension Fund
1.69%
Family Office
1.47%
Bank and Trust
0.90%
Sovereign Wealth Fund
0.24%
其他
41.19%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Phoenix Investment and Finances Ltd
37.76M
3.29%
+10.30M
+37.49%
Jun 30, 2025
Menora Mivtachim Insurance Ltd.
57.40M
5%
+18.90M
+49.10%
Jul 16, 2025
Harel Insurance Investments and Financial Services Ltd
33.39M
2.91%
+11.33M
+51.39%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
33.89M
2.95%
+833.03K
+2.52%
Jun 30, 2025
Migdal Insurance and Financial Holdings Ltd
28.69M
2.5%
+2.35M
+8.92%
Jun 30, 2025
Clal Insurance Enterprises Holdings Ltd.
32.36M
2.82%
-5.43M
-14.37%
Jun 30, 2025
Lingotto Investment Management LLP
28.16M
2.45%
+302.98K
+1.09%
Jun 30, 2025
Rubric Capital Management LP
26.00M
2.27%
+450.00K
+1.76%
Jun 30, 2025
PointState Capital LP
20.71M
1.81%
+5.58M
+36.88%
Jun 30, 2025
Fidelity Management & Research Company LLC
50.63M
4.41%
-24.67M
-32.76%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
查看更多
iShares MSCI Israel ETF
占比7.76%
VanEck Israel ETF
占比7.5%
VanEck Pharmaceutical ETF
占比3.79%
First Trust WCM Developing World Equity ETF
占比3.16%
First Trust WCM International Equity ETF
占比2.64%
ARK Israel Innovative Technology ETF
占比1.81%
WealthTrust DBS Long Term Growth ETF
占比1.42%
WisdomTree International Multifactor Fund
占比0.77%
iShares Health Innovation Active ETF
占比0.69%
iShares MSCI Intl Value Factor ETF
占比0.46%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Teva Pharmaceutical Industries Ltd的前五大股东是谁？
Teva Pharmaceutical Industries Ltd 的前五大股东如下：
Phoenix Investment and Finances Ltd持有股份：37.76M，占总股份比例：3.29%。
Menora Mivtachim Insurance Ltd.持有股份：57.40M，占总股份比例：5.00%。
Harel Insurance Investments and Financial Services Ltd持有股份：33.39M，占总股份比例：2.91%。
BlackRock Institutional Trust Company, N.A.持有股份：33.89M，占总股份比例：2.95%。
Migdal Insurance and Financial Holdings Ltd持有股份：28.69M，占总股份比例：2.50%。
Phoenix Investment and Finances Ltd持有股份：37.76M，占总股份比例：3.29%。
Menora Mivtachim Insurance Ltd.持有股份：57.40M，占总股份比例：5.00%。
Harel Insurance Investments and Financial Services Ltd持有股份：33.39M，占总股份比例：2.91%。
BlackRock Institutional Trust Company, N.A.持有股份：33.89M，占总股份比例：2.95%。
Migdal Insurance and Financial Holdings Ltd持有股份：28.69M，占总股份比例：2.50%。
Teva Pharmaceutical Industries Ltd的前三大股东类型是什么？
Teva Pharmaceutical Industries Ltd 的前三大股东类型分别是：
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
有多少机构持有Teva Pharmaceutical Industries Ltd(TEVA)的股份？
截至2025Q3，共有1124家机构持有Teva Pharmaceutical Industries Ltd的股份，合计持有的股份价值约为742.23M，占公司总股份的64.70%。与2025Q2相比，机构持股有所增加，增幅为-0.61%。
哪个业务部门对Teva Pharmaceutical Industries Ltd的收入贡献最大？
在FY2025Q2，Generic products业务部门对Teva Pharmaceutical Industries Ltd的收入贡献最大，创收2.41B，占总收入的57.73%。
